War­ren Buf­fett gets a dou­ble take as the in­vest­ment pow­er­house set­tles on its first biotech in­vest­ment

Coke. Amer­i­can-Ex­press. Ap­ple. And Bio­gen?

War­ren Buf­fet’s Berk­shire Hath­away, which made it­self in­to a sym­bol of rock-sol­id in­vest­ment strat­e­gy, has re­vealed a stake in the big biotech as it takes on one of the biggest gam­bles in the in­dus­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER